Study Field definition

Study Field means, with respect to a particular Study, the specific type(s) of cancer identified in the Study Plan.
Study Field means a set of study programmes the title of which is entered in a higher education diploma along with the title of a qualification degree.
Study Field means the use of Designated Biomarkers for genetic screening purposes related to weight loss, obesity, and metabolic syndrome, as described in the Protocol, including diabetes and dislipidemia.

Examples of Study Field in a sentence

  • Environmental Monitoring and Assessment Program-Surface Waters Western Pilot Study: Field Operation Manual for Wadeable Streams.

  • Unit II –Methods ResearchSurveys, Case Study, Field Studies General Survey of various Methods including Survey Method, Interdisciplinary Method, Case Study Method, Sampling Method, Statistical Method, Observation Method, Interview Method, Schedule Method, Questionnaire Method, Documentary Method, Library Method, Historical Method and Scientific Method.

  • The methods adopted in the assessment of HCV 5 or 6 are:• Mapping participation of locations containing elements of HCV 5 and 6,• Interview the local community, either with individual or Focus Group Discussion (FGD),• Ground assesment and analysis.The HCV Assessment PhasesThis HCV assessment is generally carried out through a series of phases such as: Desk Study, Field Survey, Data Analysis, Spatial Analysis of HCV area, and indicative HCV mapping as shown in Picture 6.

  • Additionally, either Party shall have the right to terminate a particular Study immediately upon written notice to the other Party in the event that it determines, in its sole discretion, to discontinue development of its Product within the Study Field for such Study, for medical, scientific or legal reasons.

  • Only proposed human resources by the consulting firms shall carryout Detail Feasibility Study (Field Survey) of the concerned Package of MHPs. Detail feasibility study of Micro Hydro Projects need to be done in the dry seasons and the flow measurement is need to be done between November to May as per DFS guidelines and report should be submitted as mentioned in Clause No. 6 dead line.

  • Within four (4) months following Study Completion of a given Study in the Study Field, Sponsor shall provide Regeneron with a preliminary draft of the final clinical study report and the tables and listings for such Study (“Study Results”), in electronic form.

  • Order of the Minister of Education and Science of the Republic of Lithuania On the Approval of the Description of the Law Study Field.

  • The sequence of activities completed in each home are described below and summarized in the daily activity schedule provided as Table 3.4. Table 3.4 General Schedule of Field Sampling and Inspection Activities Implemented as Part of the CPSC Study Field personnel arrived at each subject home at approximately 8:00 a.m. and began the unpacking, set-up, and calibration of equipment.

  • Survey DesignBeginning Postsecondary Students Longitudinal Study Field Test Methodology Report (BPS:90/92), NCES 92–160, by G.J. Burkheimer, Jr., B.H. Forsyth, S.C. Wheeless,K.A. Mowbray, L.M. Boehnlein, S.M. Knight, andK.J. Veith.

  • This “Work Plan for Monitoring Methane in Soil Gas” (Work Plan Addendum) is an addendum to the draft “CVOC1 Pilot Study Field Implementation Work Plan” (Work Plan; Aspect Consulting, LLC [Aspect], 2018).


More Definitions of Study Field

Study Field means an academic, professional and research field unified under a common conception, study results, and the means of attainment thereof (teaching, studying, and assessment).

Related to Study Field

  • Licensed Field means [***].

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Field of Use means all fields.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Licensed Compound means [***].

  • Licensed Territory means worldwide.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • geographical indication , in relation to goods, means an indication which identifies such goods as agricultural goods, natural goods or manufactured goods as originating, or manufactured in the territory of a country, or a region or locality in that territory, where a given quality, reputation or other characteristic of such goods is essentially attributable to its geographical origin and in case where such goods are manufactured goods one of the activities of either the production or of processing or preparation of the goods concerned takes place in such territory, region or locality, as the case may be.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Initial Indication means the use of a Product for the treatment of opioid addiction.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.